New antipsychotic drugs for the treatment of agitation and psychosis in Alzheimer’s disease: focus on brexpiprazole and pimavanserin New antipsychotic drugs for the treatment of agitation and psychosis in Alzheimer’s disease: focus on brexpiprazole and pimavanserin New antipsychotic drugs for the treatment of agitation and psychosis in Alzheimer’s disease: focus on brexpiprazole and pimavanserin Giuseppe Caruso2021-09-05T11:55:49+01:00July 8th, 2020|Pharmacology and diseases| Caraci F, Santagati M, Caruso G, Cannavò D, Leggio [...]
